Testicular Cancer Cure

A disease that only strikes young men, testicular cancer is practically synonymous with IU. In the early 1970s it had a mortality rate of ninety percent. Today, it has a survival rate of ninety-five percent. Its most famous victim, Lance Armstrong, is living proof of this.

While the mysteries of cancer continue to evade physicians and researchers, one piece of the mystery was solved in 1974 when Dr. Lawrence Einhorn of the IU School of Medicine developed a new chemotherapy regimen to treat testicular cancer.

Dr. Einhorn developed his new treatment by combining chemotherapy drugs. What was an experiment at the time became a revolutionary cancer cure. In 1996 he led the team that treated cyclist Lance Armstrong. Armstrong’s cancer had spread to his brain when he arrived at the IU Cancer Center. However, like hundreds before him, he survived. Armstrong then went on to win five Tour de France races.

Resources:

Learn more about Dr. Einhorn and his career.

Hear the stories of other cancer patients successfuly treated at IU.

Testicular cancer is the most common type of cancer in young men. Learn how testicular cancer is diagnosed.

September 20, 2003